mirtazapine has been researched along with Reperfusion Injury in 1 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tok, A | 1 |
| Sener, E | 1 |
| Albayrak, A | 1 |
| Cetin, N | 1 |
| Polat, B | 1 |
| Suleyman, B | 1 |
| Akcay, F | 1 |
| Suleyman, H | 1 |
1 other study available for mirtazapine and Reperfusion Injury
| Article | Year |
|---|---|
Effect of mirtazapine on oxidative stress created in rat kidneys by ischemia-reperfusion.
Topics: Animals; Kidney; Male; Mianserin; Mirtazapine; Oxidative Stress; Rats; Rats, Wistar; Reperfusion Inj | 2012 |